Ranibizumab Intraocular and Synapryn FusePaq
Determining the interaction of Ranibizumab Intraocular and Synapryn FusePaq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tramadol
Brand name: ConZip, Ultram, Ultram ER, Rybix ODT, Ryzolt
Synonyms: Tramadol, TraMADol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Syndros
- Ranibizumab Intraocular-Synera
- Ranibizumab Intraocular-Synercid
- Ranibizumab Intraocular-Synjardy
- Ranibizumab Intraocular-Synjardy XR
- Ranibizumab Intraocular-Synribo
- Synapryn FusePaq-Ranibizumab ophthalmic
- Synapryn FusePaq-Ranitidine
- Synapryn FusePaq-Ranitidine Capsule
- Synapryn FusePaq-Ranitidine Hydrochloride
- Synapryn FusePaq-Ranitidine Injection
- Synapryn FusePaq-Ranitidine Suspension